Category Archives: Depakote

Featured Stories

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

Study Links Liquid in E-Cigarette to Viral Infections

Study Links Liquid in Electronic Cigarette to Increased Risk of Viral Infections

The National Jewish Health study, links the liquid used in e-cigarettes to a higher risk of respiratory viral infections, whether the liquid contains nicotine or not.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Transvaginal Mesh a Nightmare for Thousands of Women

Thousands of women who have received transvaginal mesh surgical implants to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are now living a nightmare, thanks to debilitating pain, bleeding, infection and other serious complications. According to the Sun-Sentinel, many of the women injured by transvaginal mesh claim ...

Read More

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Study: Epilepsy Drug, Valproate, Linked to Increased Autism Risks

Use of anticonvulsant drug valproate by expectant mothers has been linked to an increased autism risk in their babies, a new study reveals. Valproate is used in the treatment of epilepsy, said the Global Times; however, its use by pregnant … Continue reading

Posted in Depakote, Legal News, Pharmaceuticals |

Abbot Hit With Massive Off-Label Fines

Abbott Laboratories was just hit with a massive fine for off-label practices, the second-largest such criminal fine for a single medication. A federal district judge in Virginia ordered Abbott Laboratories to pay a $500 million criminal fine and a forfeiture … Continue reading

Posted in Depakote, Legal News, Pharmaceuticals |

Lawsuits Claim Abbott Illegally Marketed Depakote

A total of 26 women have recently filed lawsuits claiming the makers of the anti-seizure drug Depakote illegally marketed the drug for off-label purposes and failed to warn of the side effects of the drug. Each of the women, according … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged |

Abbott Pleads Guilty In Depakote Marketing Case, Agrees to Pay $1.5 Billion to Resolve Justice Department Charges

It was announced yesterday that Abbott Laboratories has pleaded guilty in a Depakote marketing case. According to the U.S. Department of Justice, Abbott promoted the drug for nonapproved uses. Depakote (divalproex sodium) is an anti-seizure medication approved to treat epilepsy, … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged |

Depakote Legal Troubles Not Over for Abbott

Depakote continues to pose more legal challenges for Abbott Laboratories (ABT). Among other issues, the company has allegedly violated consumer protection laws in relation to Depakote’s sale and marketing. After allegations of off-market labeling and U.S. Justice Department investigation last … Continue reading

Posted in Depakote, Pharmaceuticals |

Depakote During Pregnancy Linked to Autism Spectrum Disorder

A new study has found more evidence that Depakote may be dangerous to a developing fetus. The study, conducted by Danish researchers, concluded that children who are exposed to valproate, the active ingredient in Depakote, face nearly three times the … Continue reading

Posted in Depakote, Pharmaceuticals |

Pending Depakote Settlement Sparks Abbott Shareholder Lawsuit

Shareholders of Abbott Laboratories have filed a lawsuit stemming from the drug maker’s pending settlement with the federal government over charges it illegally marketed the anti-seizure medication, Depakote (valproic acid), for off-label uses. The lawsuit, which was filed in Illinois … Continue reading

Posted in Depakote, Pharmaceuticals |

Depakote in Pregnancy May Cause Cognitive Impairment

The U.S. Food and Drug Administration (FDA) has warned the public that children born to women who take the anti-seizure medication < "http://www.yourlawyer.com/topics/overview/depakote">Depakote (valproate sodium) or related products (valproic acid and divalproex sodium), when pregnant, may give birth to babies … Continue reading

Posted in Depakote, Pharmaceuticals |

Fetal Exposure to Depakote, Similar Epilepsy Drugs May Impair Cognitive Development

Valproate medications, including < "http://www.yourlawyer.com/topics/overview/Depakote-Lawsuit-Lawyer-Birth-Defects">Depakote, Depakon, Depakene and Stavzor, may negatively impact a child’s IQ if they are taken during pregnancy. The U.S. Food & Drug Administration (FDA) announced yesterday that it will be revising the labels of all valproate … Continue reading

Posted in Depakote, Pharmaceuticals |

Epilepsy Drugs May Up Risk of Pregnancy Complications

Recently, we’ve done quite a bit of reporting on the link between epilepsy drugs like < "http://www.yourlawyer.com/topics/overview/Depakote-Lawsuit-Lawyer-Birth-Defects">Depakote and birth defects. Now a new study finds that such drugs might also increase the risk that pregnant women who take them will … Continue reading

Posted in Depakote, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.